131 related articles for article (PubMed ID: 10218170)
1. Serum insulin-like growth factors IGF-I and IGFBP-3 in children with slipped capital femoral epiphysis.
Nicolai RD; Grasemann H; Oberste-Berghaus C; Hövel M; Hauffa BP
J Pediatr Orthop B; 1999 Apr; 8(2):103-6. PubMed ID: 10218170
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study.
Andrade Olivié MA; García-Mayor RV; González Lestón D; Rodríguez Sousa T; Segura Dominguez A; Alvarez-Novoa R; Antelo Cortizas J
Pediatr Res; 1995 Aug; 38(2):149-55. PubMed ID: 7478808
[TBL] [Abstract][Full Text] [Related]
4. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
Löfqvist C; Andersson E; Gelander L; Rosberg S; Hulthen L; Blum WF; Wikland KA
J Clin Endocrinol Metab; 2005 Mar; 90(3):1420-7. PubMed ID: 15598696
[TBL] [Abstract][Full Text] [Related]
5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
6. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
[TBL] [Abstract][Full Text] [Related]
7. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
[TBL] [Abstract][Full Text] [Related]
10. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
[TBL] [Abstract][Full Text] [Related]
11. Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages.
Kanbur-Oksüz N; Derman O; Kinik E
Turk J Pediatr; 2004; 46(4):315-21. PubMed ID: 15641264
[TBL] [Abstract][Full Text] [Related]
12. Skeletal immaturity, IGF-I and IGFBP-3 serum concentrations in Legg-Calvé-Perthes disease (skeletal immaturity, IGF-I and IGFBP-3 in LCPD).
Grasemann H; Nicolai RD; Hauffa BP; Reinhardt W; Nicolai H; Hövel M
Klin Padiatr; 1996; 208(6):339-43. PubMed ID: 8962421
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus.
Cinaz P; Kendirci M; Kurtoglu S; Gökçora N; Buyan N; Yavuz I; Demir A
J Pediatr Endocrinol Metab; 1996; 9(4):475-82. PubMed ID: 8910817
[TBL] [Abstract][Full Text] [Related]
15. [Reference values for IGF-I, IGFBP-1, IGFBP-3 and osteocalcin in healthy children in Zaragoza].
Cortés Blanco A; Labarta Aizpún JI; Ferrández Longás A; Mayayo Dehesa E
An Esp Pediatr; 1999 Aug; 51(2):167-74. PubMed ID: 10495504
[TBL] [Abstract][Full Text] [Related]
16. Assessment of insulin like growth factor-1 and IGF binding protein-3 in healthy Indian girls from Delhi and their correlation with age, pubertal status, obesity and thyroid hormonal status.
Marwaha RK; Garg MK; Gupta S; Khurana AK; Narang A; Shukla M; Arora P; Chadha A; Nayak DD; Manchanda RK
J Pediatr Endocrinol Metab; 2017 Jul; 30(7):739-747. PubMed ID: 28672739
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3).
Elmlinger MW; Kühnel W; Weber MM; Ranke MB
Clin Chem Lab Med; 2004; 42(6):654-64. PubMed ID: 15259383
[TBL] [Abstract][Full Text] [Related]
18. [Determination of skeletal age using the Oxford Score in children with epiphyseolysis of the femur head].
Vick S; Jaster D; Kundt G; Plath J; Schulze R
Z Orthop Ihre Grenzgeb; 1996; 134(4):305-8. PubMed ID: 8928557
[TBL] [Abstract][Full Text] [Related]
19. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
20. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
